Aditxt, Inc. is a biotech company that works on immune mapping and reprogramming to improve immune system health. Their AditxtScore and Apoptotic DNA Immunotherapy technologies help individuals manage, monitor and understand their immune profiles and induce tolerance to the body's tissues. The company is also developing ADi products for organ transplantation, autoimmune diseases, allergies, and has license agreements with Loma Linda University and Leland Stanford Junior University.